Company News, Financial News

DSM and Amyris Close Brazilian Deal

DSM expands alliance with facility acquisition.

Author Image

By: TOM BRANNA

Editor

Amyris, Inc. has completed the sale of Amyris Brasil Ltda to DSM and, with it, established a long-term manufacturing partnership for Amyris’ high-volume products. The consideration for Amyris Brasil Ltda (which owns and operates the Brotas 1 production facility) and intellectual property related to farnesene (a bio-based key intermediate for many applications) is $58 million plus an additional value share arrangement over a three-year period amounting to $37.5 million (aggregate upfront conside...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters